Phaim Pharma Ltd. – Trademark Portfolio
Entity Type: 99
Phaim Pharma Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PHAIM and PHAIM AIM ANTIGENIC IMMUNE MODULATION. The owner is based in London.
One Bartholomew Close
London EC1A7BL , GB
Showing of trademarks Trademarks
Trademark Classifications
Phaim Pharma Ltd.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Phaim Pharma Ltd. have?
Phaim Pharma Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Phaim Pharma Ltd. file in?
Phaim Pharma Ltd. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Phaim Pharma Ltd.'s most well-known trademarks?
Phaim Pharma Ltd.'s registered trademark portfolio includes well-known marks such as PHAIM and PHAIM AIM ANTIGENIC IMMUNE MODULATION. These are among 3 currently registered trademarks in the portfolio.
What is Phaim Pharma Ltd.'s trademark registration success rate?
Phaim Pharma Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.